A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice.
about
Lactoferrin: A Modulator for Immunity against Tuberculosis Related Granulomatous PathologyLactoferrin modulation of mycobacterial cord factor trehalose 6-6'-dimycolate induced granulomatous response.Novel recombinant human lactoferrin: differential activation of oxidative stress related gene expressionPost-Spaceflight (STS-135) Mouse Splenocytes Demonstrate Altered Activation Properties and Surface Molecule ExpressionInfluence of oral lactoferrin on Mycobacterium tuberculosis induced immunopathology.Comparing efficacy of BCG/lactoferrin primary vaccination versus booster regimen.OX40 ligand fusion protein delivered simultaneously with the BCG vaccine provides superior protection against murine Mycobacterium tuberculosis infection.Lactoferrin restrains allergen-induced pleurisy in mice.Pulmonary Tuberculosis in Humanized Mice Infected with HIV-1TB research at UT-Houston--a review of cord factor: new approaches to drugs, vaccines and the pathogenesis of tuberculosis.Lactoferrin: Balancing Ups and Downs of Inflammation Due to Microbial Infections.Oral recombinant human or mouse lactoferrin reduces Mycobacterium tuberculosis TDM induced granulomatous lung pathology.CHO expressed recombinant human lactoferrin as an adjuvant for BCG.Effects of CHO-expressed recombinant lactoferrins on mouse dendritic cell presentation and function.Lactoferrin Augmentation of the BCG Vaccine Leads to Increased Pulmonary Integrity.Lactoferrin in a Context of Inflammation-Induced Pathology.Immunogenicity of heparin-binding hemagglutinin expressed by Pichia pastoris GS115 strain.Recombinant human lactoferrin modulates human PBMC derived macrophage responses to BCG and LPS.
P2860
Q26770855-5C9790F5-28FB-4DCF-8663-146A53014216Q34166235-B42116B0-E625-4822-95E7-BD640007A186Q35000274-D6E03831-E520-4929-83DB-5608CEF17862Q35602005-A9009C25-AB20-43CF-B56B-D97DFEB76ED1Q35643199-DE0F3A40-BA9C-45AC-9C11-2EC2B9A1D615Q35643237-113DAF68-752A-4155-A3DD-937E4E001B31Q35766002-2D3A8628-B4B6-4B4E-A4D6-9B4EF65675D9Q36319653-1B83D830-566C-4552-A59A-BD808FE4D9F1Q36731941-48A449E5-5BD2-4156-AB88-D9D84C986FF3Q36929373-034C0AC7-5D90-4D53-BE30-51186C547B96Q39159902-E877D259-8BEB-4BEB-B8CA-4A6B06B2B1E6Q40343798-1306D3D9-3FA9-40DE-AE56-BFE6838B9B6DQ41028714-53E842B7-6F22-4C65-AD88-6682A3523F2BQ41583738-03C99D59-604A-4169-9DE8-E4512D8E40FCQ42134087-C8EBBBBB-73EC-4AA7-A461-65F923BF3A1AQ46256576-440B8F52-BF80-460C-8CDE-04D7A65BC1F9Q49874170-976EBF56-DFD7-4101-9160-2AF727B3C606Q51407200-E31C1DA5-E4D0-4819-A052-4E7340208909
P2860
A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A novel recombinant human lact ...... acterium tuberculosis in mice.
@en
A novel recombinant human lact ...... acterium tuberculosis in mice.
@nl
type
label
A novel recombinant human lact ...... acterium tuberculosis in mice.
@en
A novel recombinant human lact ...... acterium tuberculosis in mice.
@nl
prefLabel
A novel recombinant human lact ...... acterium tuberculosis in mice.
@en
A novel recombinant human lact ...... acterium tuberculosis in mice.
@nl
P2093
P2860
P1433
P1476
A novel recombinant human lact ...... acterium tuberculosis in mice.
@en
P2093
Jeffrey K Actor
Katarzyna Wilk
Marian L Kruzel
Shen-An Hwang
P2860
P304
P356
10.1016/J.VACCINE.2009.03.036
P407
P577
2009-04-05T00:00:00Z